Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02289846 | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) | PHASE2 | COMPLETED | 90 | — | — | Oct 1, 2014 | Dec 1, 2015 | Dec 5, 2016 | 22 | United States |
| Arm | Type | Description |
|---|---|---|
| Placebo BID | PLACEBO_COMPARATOR | Placebo once in the morning and once in the evening. |
| IW-9179 QD AM + Placebo QD PM | EXPERIMENTAL | IW-9179 once in the morning and placebo once in the evening. |
| Placebo QD AM + IW-9179 QD PM | EXPERIMENTAL | Placebo once in the morning and IW-9179 once in the evening. |
| IW-9179 BID | EXPERIMENTAL | IW-9179 once in the morning and once in the evening |
| Name | Type | Description |
|---|---|---|
| IW-9179 | DRUG | - |
| Matching Placebo | DRUG | - |
Inclusion Criteria: * Patient is a male or non-pregnant, non-breastfeeding female, and is age 18 years or older at the time of the Screening Visit. * Patient has a confirmed diagnosis of type 1 or type 2 diabetes mellitus. * Patient has a diagnosis of DGP with no history or evidence of mechanical o...